agilon health, inc. - Common stock, par value $0.01 (AGL)

Historical Holders from Q2 2021 to Q4 2025

Type / Class
Equity / Common stock, par value $0.01
Symbol
AGL on NYSE
Shares outstanding
414,862,705
Price per share
$0.6888
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
381,662,119
Total reported value
$393,142,577
% of total 13F portfolios
0%
Share change
-19,007,897
Value change
-$40,920,615
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
187
Price from insider filings
$1.11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of agilon health, inc. - Common stock, par value $0.01 (AGL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 12% $276,101,370 50,200,249 Morgan Stanley 31 Mar 2025
North Peak Capital Management, LLC 9.5% +86% $40,594,316 +$18,411,536 39,411,957 +83% North Peak Capital Management, LLC 30 Sep 2025
VANGUARD GROUP INC 5.9% $25,021,381 24,292,603 The Vanguard Group 30 Sep 2025
FMR LLC 3.7% -63% $15,838,857 -$24,084,688 15,377,531 -60% FMR LLC 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 3.6% -47% $82,427,934 -$73,649,284 14,986,897 -47% Wellington Management Group LLP 31 Mar 2025
Capital World Investors 2.6% -76% $14,108,826 -$45,132,955 10,852,943 -76% Capital World Investors 29 Aug 2025
Capital International Investors 2.4% -60% $12,860,565 -$16,170,870 9,892,742 -56% Capital International Investors 30 Jun 2025
As of 30 Sep 2025, agilon health, inc. - Common stock, par value $0.01 (AGL) has 187 institutional shareholders filing 13F forms. They hold 381,662,119 shares of 414,862,705 outstanding shares (92%) .

Top 25 institutional shareholders own 87% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Clayton, Dubilier & Rice, LLC 24% 100,000,000 0% 15% $103,000,000
MORGAN STANLEY 14% 59,384,795 +3.8% 0% $61,166,339
North Peak Capital Management, LLC 8.3% 34,424,477 4% $35,457,211
VANGUARD GROUP INC 5.9% 24,292,603 -20% 0% $25,021,381
BlackRock, Inc. 5.8% 24,197,634 -2.3% 0% $24,923,563
FMR LLC 3.8% 15,645,831 -60% 0% $16,115,206
CenterBook Partners LP 2.8% 11,428,027 +492% 0.58% $11,770,868
D. E. Shaw & Co., Inc. 2.4% 9,993,871 +601% 0.01% $10,293,687
Capital World Investors 2% 8,364,227 -82% 0% $8,615,154
Capital International Investors 2% 8,232,209 -17% 0% $8,479,175
STATE STREET CORP 1.9% 7,707,516 +0.08% 0% $7,938,741
GEODE CAPITAL MANAGEMENT, LLC 1.7% 7,142,423 -0.2% 0% $7,357,677
Rock Springs Capital Management LP 1.7% 6,966,300 +6.3% 0.42% $7,175,289
GOLDMAN SACHS GROUP INC 1.6% 6,771,284 +20% 0% $6,974,422
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 6,125,568 +23% 0% $6,309,335
BANK OF AMERICA CORP /DE/ 1.3% 5,414,614 +41% 0% $5,577,052
CITADEL ADVISORS LLC 0.93% 3,856,211 +4% 0% $3,971,897
JACOBS LEVY EQUITY MANAGEMENT, INC 0.75% 3,099,850 +69% 0.01% $3,192,845
Nuveen, LLC 0.74% 3,065,008 +8.8% 0% $3,156,958
MILLENNIUM MANAGEMENT LLC 0.72% 2,998,838 +280% 0% $3,088,803
Voleon Capital Management LP 0.66% 2,741,039 +5519% 0.07% $2,823,270
NORTHERN TRUST CORP 0.64% 2,649,258 -2.2% 0% $2,728,736
JPMORGAN CHASE & CO 0.51% 2,105,297 +209% 0% $2,168,456
JANE STREET GROUP, LLC 0.45% 1,860,037 +6184% 0% $1,915,838
RENAISSANCE TECHNOLOGIES LLC 0.35% 1,459,600 +72% 0% $1,503,388

Institutional Holders of agilon health, inc. - Common stock, par value $0.01 (AGL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 642,337 $486,525 +$204,603 68.88% 6
2025 Q3 381,662,119 $393,142,577 -$40,920,615 103% 187
2025 Q2 399,328,682 $918,636,706 -$2,996,467 230% 204
2025 Q1 399,816,350 $1,730,764,200 -$76,575,367 433% 197
2024 Q4 416,234,324 $791,149,148 -$38,614,989 190% 182
2024 Q3 428,060,898 $1,681,495,499 -$125,470,725 393% 209
2024 Q2 455,695,379 $2,980,243,307 +$91,121,852 654% 205
2024 Q1 441,592,252 $2,693,162,077 -$209,537,591 610% 198
2023 Q4 138,520 $1,738,426 -$36,244 1,255% 2
2023 Q3 450,217,026 $7,996,295,875 +$203,861,636 1,776% 189
2023 Q2 438,373,717 $7,601,102,347 -$167,106,645 1,734% 184
2023 Q1 447,304,552 $10,625,731,292 +$379,139,950 2,375% 201
2022 Q4 431,456,790 $6,966,725,030 +$106,964,427 1,614% 164
2022 Q3 423,166,285 $9,910,037,692 +$181,972,956 2,342% 167
2022 Q2 405,695,266 $8,857,695,141 +$270,134,040 2,183% 139
2022 Q1 399,667,807 $10,129,841,658 +$205,085,675 2,534.98% 117
2021 Q4 390,522,322 $10,544,194,856 +$1,572,328,102 2,700% 123
2021 Q3 332,203,125 $8,682,987,469 +$7,832,213 2,621% 100
2021 Q2 330,692,941 $13,289,868,180 +$13,289,858,190 4,057% 92